[Federal Register Volume 62, Number 84 (Thursday, May 1, 1997)]
[Notices]
[Page 23779]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-11293]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Scientific Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) has made a final finding of scientific misconduct in the
following case:
William G. McCown, Ph.D., Integra, Inc.: Based upon a report
forwarded to the Office of Research Integrity (ORI) by Compass
Information Services, Inc., and information obtained by ORI during its
oversight review, ORI found that Dr. McCown, former Project Director at
Integra, Inc. (now Compass Information Services, Inc.), engaged in
scientific misconduct by falsifying answer sheets for an ``Item Count
Substance Abuse Survey'' supported by a grant from the National
Institute on Drug Abuse (NIDA), National Institutes of Health (NIH).
Dr. McCown has entered into a Voluntary Exclusion Agreement with
ORI in which he does not admit to any acts of scientific misconduct but
has voluntarily agreed, for the three (3) year period beginning April
17, 1997:
(1) To exclude himself from serving in any advisory capacity to the
Public Health Service (PHS), including but not limited to service on
any PHS advisory committee, board, and/or peer review committee, or as
a consultant; and
(2) That any institution that submits an application for PHS
support for a research project on which Dr. McCown's participation is
proposed or which uses him in any capacity on PHS supported research
must concurrently submit a plan for supervision of his duties. The
supervisory plan must be designed to ensure the scientific integrity of
Dr. McCown's research contribution. The institution must submit a copy
of the supervisory plan to ORI.
No scientific publications were required to be corrected as part of
this Agreement.
FOR FURTHER INFORMATION CONTACT: Acting Director, Division of Research
Investigations, Office of Research Integrity, 5515 Security Lane, Suite
700, Rockville, MD 20852, (301) 443-5330.
Chris B. Pascal,
Acting Director, Office of Research Integrity.
[FR Doc. 97-11293 Filed 4-30-97; 8:45 am]
BILLING CODE 4160-17-P
